Less Ads, More Data, More Tools Register for FREE

The UK's Largest Investor Community

Indices

Indices Value Chg %
FTSE 10010,345.48 90.670.88%
FTSE 25023,033.95 82.610.36%
FTSE 3505,624.34 46.200.83%
FTSE All-Share5,562.87 45.430.82%
FTSE Small Cap7,814.65 34.940.45%

Most Traded on Thursday 11th June

Company Price Value Trades
Halma (HLMA)3,886.00 £127,035.97k35,465
Rolls-Royce (RR.)1,247.60 £50,987.08k32,916
Taylor Wimpey (TW.)74.96 £9,309.25k23,669
Shell (SHEL)3,289.50 £133,838.37k19,925
Rio Tinto (RIO)7,566.00 £83,344.28k19,694
Company Price Value Volume
Unilever (ULVR)4,385.50 £164,051.79k2,871,135
Shell (SHEL)3,289.50 £133,838.37k4,355,862
Halma (HLMA)3,886.00 £127,035.97k3,241,760
HSBC Holdings (HSBA)1,323.40 £120,541.57k9,325,172
BP (BP.)547.90 £114,266.36k14,261,674

Sector Activity

01:05

Wishbone Gold PLC: Red Setter Gold-Copper Project Update

Wishbone Gold ( WSBN ) provides an update on drilling progress at its Red Setter Gold-Copper Project in Western Australia's Paterson Province. The 2026 exploration programme is advancing as planned...

01:30

New RetailBook Investment Opportunity: WH Smith (SMWH)

WHSmith ( SMWH ) announces a conditional retail offer of new Ordinary Shares via RetailBook. - The Retail Offer is available to both existing shareholders and new investors; - The issue price ...

14:41

Peloton Minerals is raising CAD$4m to fund development of its North Elko project in Nevada

Peloton Minerals Corporation (CSE; PMC: OTCQB; PMCCF) is raising CAD$4.0m to fund the exploration of the company’s North Elko project in Nevada, USA. As announced on 28 May 2026, the Company has al...

Level 2 Order Book Level 2

The Level 2 Order Book shows what the market makers are doing – what price they are prepared to buy or sell at. The order book also shows whether there are more buy orders or sell orders and can indicate the next price movement.

Get Level 2 NOW

Featured Investment Trust

Polar Capital Global Healthcare Trust plc (PCGH)

As a specialist healthcare investment trust, PCGH focusses on powerful growth stories, from disruptive biotech to global pharmaceuticals. With a globally diversified approach, PCGH accesses multi-decade themes while expertly navigating near-term volatility with its bias to large, defensive companies.

Find Out More

Sign up to London South East Newsletters